The Sweetener Wars | Attack of the Cancer Rats | 1
Summary
This episode details the rise of Sweet'n Low and its rivalry with Searle’s Equal. After a cyclamate ban threatened Cumberland Packing, Marvin Eisenstadt pivoted to saccharin, securing market dominance. Later, Searle’s Donald Rumsfeld pushed aspartame through regulatory hurdles, launching Equal to challenge Sweet'n Low. The story highlights aggressive marketing, political lobbying, and ends with the discovery of internal fraud within Cumberland.
Topics discussed
Introduction and Audible sponsorship
Cyclamate ban forces Sweet'n Low to switch to saccharin
Brief interlude: Dangerous suspect manifesto
Sweet'n Low dominates market with new formula
The high-stakes world of sugar substitutes
Cumberland Packing's history and early innovations
Marvin Eisenstadt faces potential saccharin ban on TV
Public panic and temporary reprieve for saccharin
Audible promo: Unreal podcast
Donald Rumsfeld takes charge at struggling Searle
Discovery of aspartame and regulatory hurdles
Rumsfeld sues FDA and leverages political connections
Searle's failed attempt to buy Sweet'n Low
Launch of Equal and NutraSweet brand strategy
Searle targets the diet soda market
Audible promo: Pride and Prejudice
Diet Coke vs Diet Pepsi: The NutraSweet war
Equal expands market share against Sweet'n Low
Sweet One launch and discovery of supplier fraud
Episode conclusion and credits
Teaser for American Scandal: The Rosenbergs
Listen ad-free on Castria